Lynn and colleagues also published a paper on FRβ-redirected CAR-T-mediated targeting of AML blasts, based on the findings that FRβ expression has been evident in a high percentage of AML samples (90). This evidence concerns the gene FOLR2 and acute myeloid leukemia.